Lipoprotein(a) Lowering—From Lipoprotein Apheresis to Antisense Oligonucleotide Approach

It is well-known that elevated lipoprotein(a)—Lp(a)—levels are associated with a higher risk of cardiovascular (CV) mortality and all-cause mortality, although a standard pharmacotherapeutic approach is still undefined for patients with high CV risk dependent on hyperlipoproteinemia(a). Combined wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Greco, Maria Francesca, Sirtori, Cesare R., Corsini, Alberto, Ezhov, Marat, Sampietro, Tiziana, Ruscica, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408876/
https://www.ncbi.nlm.nih.gov/pubmed/32635396
http://dx.doi.org/10.3390/jcm9072103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408876/
https://www.ncbi.nlm.nih.gov/pubmed/32635396
http://dx.doi.org/10.3390/jcm9072103

Ejemplares similares